GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (STU:2RH) » Definitions » Inventories, Raw Materials & Components

Redhill Biopharma (STU:2RH) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Redhill Biopharma Inventories, Raw Materials & Components?

Redhill Biopharma's inventories, raw materials & components for the quarter that ended in Jun. 2024 was €0.00 Mil.

Redhill Biopharma's quarterly raw materials increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.76 Mil) but then declined from Dec. 2023 (€0.76 Mil) to Jun. 2024 (€0.00 Mil).

Redhill Biopharma's annual raw materials declined from Dec. 2021 (€2.67 Mil) to Dec. 2022 (€1.70 Mil) and declined from Dec. 2022 (€1.70 Mil) to Dec. 2023 (€0.76 Mil).


Redhill Biopharma Inventories, Raw Materials & Components Historical Data

The historical data trend for Redhill Biopharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Inventories, Raw Materials & Components Chart

Redhill Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 1.47 2.67 1.70 0.76

Redhill Biopharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 - - 0.76 -

Redhill Biopharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Redhill Biopharma Business Description

Industry
Traded in Other Exchanges
Address
21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Redhill Biopharma Headlines

No Headlines